Yes! Our new white paper goes beyond the headlines to uncover how GLP-1 medications work and the exciting health results for people living with obesity.
Explore what's behind all the buzz
Get the answers to your questions about GLP-1s — and their impact on obesity treatment, diabetes, heart health, and more — from internationally recognized physician and scientist Dr. Robert Kushner.
What's different about how GLP-1s work?
What are the implications for employee health?
What's next in the developing treatment of overweight and obesity?
Insights from the latest clinical trials
16.9%
average weight loss1
Lifestyle and behavioral programs accelerate the impact of the medications
20%
reduction in cardiovascular risk
1 Over 68 weeks for people taking GLP-1s
WeightWatchers for Business
We’re the only full-spectrum weight health platform built to help organizations like yours navigate the rapidly evolving landscape.
Our individualized Pathways™, based on true clinical need (condition- and medication-specific), include:
Leading behavior change with clinical and medication management
Scalable coaching and communities (digital and in-person)
Find out how WeightWatchers for Business can help your organization deliver personalized support and science-proven results while helping to control costs.
